ScoreWhy is Genomed SA ?
1
With a growth in Net Sales of 22.75%, the company declared Very Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at PLN 3.41 MM
- ROCE(HY) Highest at 30.34%
- RAW MATERIAL COST(Y) Fallen by -6.82% (YoY)
2
With ROE of 21.50%, it has a fair valuation with a 3.74 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -6.92%, its profits have risen by 154% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Genomed SA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Genomed SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Genomed SA
-6.92%
-0.20
68.77%
Poland WIG
27.62%
1.38
19.95%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.20%
EBIT Growth (5y)
37.86%
EBIT to Interest (avg)
1.04
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
2.54
Tax Ratio
5.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.90%
ROE (avg)
8.65%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
3.74
EV to EBIT
13.71
EV to EBITDA
10.54
EV to Capital Employed
5.58
EV to Sales
1.36
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
40.69%
ROE (Latest)
21.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PLN 3.41 MM
ROCE(HY)
Highest at 30.34%
RAW MATERIAL COST(Y)
Fallen by -6.82% (YoY
CASH AND EQV(HY)
Highest at PLN 11.71 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 11.6 times
NET SALES(Q)
Highest at PLN 8.78 MM
OPERATING PROFIT(Q)
Highest at PLN 2.22 MM
OPERATING PROFIT MARGIN(Q)
Highest at 25.31 %
PRE-TAX PROFIT(Q)
Highest at PLN 2.02 MM
NET PROFIT(Q)
Highest at PLN 1.63 MM
-2What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 0 %
EPS(Q)
Lowest at PLN 0
Here's what is working for Genomed SA
Operating Cash Flow
Highest at PLN 3.41 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PLN MM)
Net Sales
Highest at PLN 8.78 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (PLN MM)
Operating Profit
Highest at PLN 2.22 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (PLN MM)
Operating Profit Margin
Highest at 25.31 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at PLN 2.02 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (PLN MM)
Net Profit
Highest at PLN 1.63 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (PLN MM)
Cash and Eqv
Highest at PLN 11.71 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 11.6 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -6.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Genomed SA
EPS
Lowest at PLN 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (PLN)
Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
